Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2868 results
Michael, on a large screen, speaking at Cancer Research UK's Early Diagnosis conference

Michael, who spoke at our early diagnosis conference this year, tells the story of his two cancer diagnoses and gives his perspective on the importance of early diagnosis Michael, who spoke at our early diagnosis conference this year, tells the story of his two cancer diagnoses and gives his perspective on the importance of early diagnosis

by Michael Anderson | Personal stories | 10 October 2024

10 October 2024

A radiotherapy machine in a hospital. It is tilted to show how it can move to target tumours.

A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies.  A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies. 

by Tim Gunn | News | 7 October 2024

7 October 2024

vaccine vials on a production line with a gloved hand reaching to grab one of them

Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

by Sophie Wedekind | News | 4 October 2024

4 October 2024

Microscopic image of core biopsy for infiltrating (invasive) ductal carcinoma, detected by screening mammogram

Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer

by Fiona Scott | News | 1 October 2024

1 October 2024

Radiographer looking at a mammogram image

Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​. Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​.

by Amy Warnock | In depth | 1 October 2024

1 October 2024

Caitlin, who was diagnosed with Ewing sarcoma this year and is going to take part in our INTER-EWING-1 trial.

INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.   INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.  

by Momoko Bowles | Analysis | 25 September 2024

25 September 2024

CT scan of a glioblastoma brain tumour highlighted in one section of the brain.

Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments. Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments.

by Sadaf Shafaghmotlagh | News | 24 September 2024

24 September 2024

A sample of a mouse model of a tumour seen through team Rosetta's tools.

Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good. Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good.

by Tim Gunn | In depth | 24 September 2024

24 September 2024

Researchers working in the lab at CRUK's Scotland Institute

Over the last financial year, Cancer Research UK has made significant steps towards achieving its vision of bringing about a world where everyone can live longer, better lives, free from the fear of cancer, as outlined in the charity’s latest Annual Report and Accounts, which were published today. Over the last financial year, Cancer Research UK has made significant steps towards achieving its vision of bringing about a world where everyone can live longer, better lives, free from the fear of cancer, as outlined in the charity’s latest Annual Report and Accounts, which were published today.

by Cancer Research UK | News | 11 September 2024

11 September 2024

Zhe Huang

We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer... We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer...

by Cancer Research UK | Interview | 10 September 2024

10 September 2024